SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
SNNA
Delisted
SNNA was delisted on the 16th of December, 2019.
53 hedge funds and large institutions have $151M invested in Sienna Biopharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
18% less capital invested
Capital invested by funds: $184M → $151M (-$33M)
Holders
53
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.35M | |
| 2 | +$2.74M | |
| 3 | +$1.63M | |
| 4 |
AG
Artal Group
Luxembourg
|
+$1.5M |
| 5 |
BlackRock
New York
|
+$1.48M |
Top Sellers
| 1 | -$6.76M | |
| 2 | -$5.39M | |
| 3 | -$751K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$345K |
| 5 |
CAG
Crestwood Advisors Group
Boston,
Massachusetts
|
-$206K |